Epitalon

Mechanism (as reported)

Multiple studies/reviews described mechanisms that include effects on chromatin/heterochromatin structure and gene expression, modulation of neurogenic marker expression with an epigenetic component involving histone binding, influences on melatonin synthesis, and activation of telomerase/telomere-length related pathways in cell lines. (PMIDs: 32019204, 16634527, 40141333, 12374906, 40908429)

Key findings (each cites a source)

• A review reported that Epitalon (Ala-Glu-Asp-Gly; Epithalon/Epithalone) has been extensively studied over ~25 years using in vitro, in vivo, and in silico methods, with reported antioxidant, neuro-protective, and antimutagenic effects, as well as geroprotective and neuroendocrine effects. [PMID 40141333]
• The review described that Epitalon has been reported to directly influence melatonin synthesis, alter mRNA levels of interleukin-2, modulate mitogenic activity of murine thymocytes, and enhance enzyme activities including AChE, BuChE, and telomerase, while noting uncertainty about whether these are the sole mechanisms. [PMID 40141333]
• Research investigated an epigenetic mechanism proposal for AEDG (Epitalon) in neurogenesis, reporting increased synthesis and mRNA expression of neurogenic differentiation markers (Nestin, GAP43, β-Tubulin III, Doublecortin) in human gingival mesenchymal stem cells, alongside molecular modeling suggesting binding preferences to H1/6 and H1/3 histones in DNA-interacting sites. [PMID 32019204]
• A review stated that Epitalon reproduces effects attributed to Epithalamin, including reported increases in lifespan in mice and fruit flies and restoration of circadian rhythms of melatonin and cortisol production in old rhesus monkeys. [PMID 12374906]
• A mouse study reported that long-term exposure to Epitalon in small doses did not show toxic effects and decreased the number of tumor-bearing mice with malignant tumors, prevented development of metastases, and slowed metastasis development from spontaneous tumors in the tested model. [PMID 16634527, 40141333]
• Research reported that Epitalon induces chromatin activation in lymphocytes from older persons, including activation of ribosomal genes, decondensation of pericentromeric structural heterochromatin, and release of genes repressed due to age-related condensation of euchromatic regions. [PMID 14647006]
• An in vitro oocyte study reported that Epitalon reduced intracellular reactive oxygen species and decreased frequency of spindle defects and abnormal cortical granule distribution during post-ovulatory aging, and was associated with increased mitochondrial membrane potential and mitochondrial DNA copy number and decreased apoptosis by 24 hours. [PMID 35413689]
• A cell-line study reported that Epitalon increased telomere length via telomerase upregulation (hTERT mRNA upregulation and increased telomerase activity) in normal cells, and that telomere length extension in cancer cell lines also occurred through ALT activation (with only minor ALT activity reported in normal cells). [PMID 40908429]
• In HER-2/neu transgenic mice, research reported that Epitalon reduced cumulative mammary tumor number and maximum size, reduced the number of mice bearing 2 or more mammary tumors compared with saline, and reduced lung metastasis size (not number). It also reported a 3.7-fold reduction in HER-2/neu mRNA expression in mammary tumors from Epitalon-treated mice relative to control. [PMID 12209581]